US Patent 7332471 Cross-linked glycopeptide-cephalosporin antibiotics
Patent 7332471 was granted and assigned to Theravance on February, 2008 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 30, 2006
Date of Patent
February 19, 2008
Patent Application Number
11342729
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7332471 Cross-linked glycopeptide-cephalosporin antibiotics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.